Every SEC Form 3/4/5 on record for this filer (CIK 1733094) — 2 issuers, 149 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| ADMA | ADMA BIOLOGICS, INC. | Director | 2021-10-18 → 2026-02-11 | 10 | −$898,100 |
| MNTA | MOMENTA PHARMACEUTICALS INC | Chief Financial & Bus. Officer · lapsed | 2018-03-12 → 2020-10-01 | 43 | −$7M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| ADMA | 2024-08-23 | Sell | 60,000 | $18.26 | $1M | 241,441 |
| ADMA | 2023-08-24 | Buy | 25,000 | $3.90 | $97,500 | 277,401 |
| ADMA | 2021-10-25 | Buy | 100,000 | $1.00 | $100,000 | 200,000 |
| MNTA | 2020-08-10 | Sell | 652 | $32.36 | $21,099 | 160,633 |
1 of 2 issuers are covered and open a security page; the rest are on file here only.
